Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer

Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer

After being stagnant for decades, there has finally been a paradigm shift in the treatment of small-cell lung cancer (SCLC) with the emergence and application of immune checkpoint inhibitors (ICIs). Multiple trials of first-line ICI-chemotherapy combinations have demonstrated survival benefit compar...

Full description

Bibliographic Details
Main Authors: Selina K. Wong, Wade T. Iams
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
small-cell lung cancer
immunotherapy
immune checkpoint inhibitors
Online Access:https://www.mdpi.com/2072-6694/13/3/506

Similar Items

Similar Items